ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling

Molecular and Cellular Biology

Volumn 31, Issue 14, 2011, Pages 3052-3067

  Pillai, Smitha ^a   Rizwani, Wasia ^a   Li, Xueli ^a   Rawal, Bhupendra ^a   Nair, Sajitha ^a   Schell, Michael J ^a   Bepler, Gerold ^a,b   Haura, Eric ^a   Coppola, Domenico ^a   Chellappan, Srikumar ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; INHIBITOR OF DIFFERENTIATION 1; K RAS PROTEIN; NICOTINE; NICOTINIC RECEPTOR; SMALL INTERFERING RNA; VIMENTIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; METASTASIS; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKING; TISSUE MICROARRAY; WESTERN BLOTTING;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LUNG; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NICOTINE; NICOTINIC AGONISTS; PROTEIN SUBUNITS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NICOTINIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSCRIPTION FACTORS; VIMENTIN;

MUS;

EID: 79960353846     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01311-10     Document Type: Article

References (72)

1. Alani, R. M., C. F. Silverthorn, and K. Orosz. 2004. Tumor angiogenesis in mice and men. Cancer Biol. Ther. 3:498-500.
2. Benezra, R. 2001. Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc. Med. 11:237-241.
3. Benezra, R., S. Rafii, and D. Lyden. 2001. The Id proteins and angiogenesis. Oncogene 20:8334-8341.
4. Bhattacharya, R., J. Kowalski, A. R. Larson, M. Brock, and R. M. Alani. 2010. Id1 promotes tumor cell migration in nonsmall cell lung cancers. J. Oncol. 2010:856105.
5. Carey, J. P., A. J. Asirvatham, O. Galm, T. A. Ghogomu, and J. Chaudhary. 2009. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer 9:173.
6. Dasgupta, P., and S. P. Chellappan. 2006. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5:2324-2328.
7. Dasgupta, P., et al. 2006. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc. Natl. Acad. Sci. U. S. A. 103:6332-6337.
8. Dasgupta, P., et al. 2006. Nicotine induces cell proliferation by beta-arrestinmediated activation of Src and Rb-Raf-1 pathways. J. Clin. Invest. 116:2208-2217.
9. Dasgupta, P., et al. 2009. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int. J. Cancer 124:36-45.
10. Davis, R., et al. 2009. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4:e7524.
11. Ding, Y., et al. 2006. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. Int. J. Oncol. 28:847-854.
12. Everly, D. N., Jr., B. A. Mainou, and N. Raab-Traub. 2004. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J. Virol. 78:13470-13478.
13. Gao, D., et al. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319:195-198.
14. Gautschi, O., et al. 2008. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res. 68:2250-2258.
15. Gilles, C., et al. 2003. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 63:2658-2664.
16. Gotti, C., and F. Clementi. 2004. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74:363-396.
17. Greulich, H., et al. 2005. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med. 2:e313.
18. Gupta, G. P., et al. 2007. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc. Natl. Acad. Sci. U. S. A. 104:19506-19511.
19. Heeschen, C., et al. 2001. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 7:833-839.
20. Heeschen, C., M. Weis, A. Aicher, S. Dimmeler, and J. P. Cooke. 2002. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J. Clin. Invest. 110:527-536.
21. Irmer, D., J. O. Funk, and A. Blaukat. 2007. EGFR kinase domain mutations-functional impact and relevance for lung cancer therapy. Oncogene 26:5693-5701.
22. Jemal, A., et al. 2009. Cancer statistics, 2009. CA Cancer J. Clin. 59:225-249.
23. Johnson, D. H., and J. H. Schiller. 2002. Novel therapies for the treatment of non-small cell lung cancer. Cancer Chemother. Biol. Response Modif. 20:763-786.
24. Kalluri, R. 2009. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119:1417-1419.
25. Lam, D. C., et al. 2007. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res. 67:4638-4647.
26. Lasorella, A., M. Noseda, M. Beyna, Y. Yokota, and A. Iavarone. 2000. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407:592-598.
27. Lasorella, A., T. Uo, and A. Iavarone. 2001. Id proteins at the cross-road of development and cancer. Oncogene 20:8326-8333.
28. Lee, K. T., et al. 2004. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. Br. J. Cancer 90:1198-1203.
29. Li, B., et al. 2009. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int. J. Cancer 125:2576-2585.
30. Li, X., et al. 2007. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer. Histopathology 50:484-490.
31. Light, W., A. E. Vernon, A. Lasorella, A. Iavarone, and C. LaBonne. 2005. Xenopus Id3 is required downstream of Myc for the formation of multipotent neural crest progenitor cells. Development 132:1831-1841.
32. Lin, C. Q., et al. 2000. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 60:1332-1340.
33. Ling, M. T., et al. 2005. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26:1668-1676.
34. Lyden, D., et al. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401:670-677.
35. Massari, M. E., and C. Murre. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:429-440.
36. Minna, J. D. 2003. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J. Clin. Invest. 111:31-33.
37. Mukhin, A. G., et al. 2008. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J. Nucl. Med. 49:1628-1635.
38. Nicholson, R. I., et al. 2001. Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer. Endocr. Relat. Cancer 8:175-182.
39. Nishimine, M., et al. 2003. Id proteins are overexpressed in human oral squamous cell carcinomas. J. Oral Pathol. Med. 32:350-357.
40. Nishiyama, K., et al. 2005. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation 112:2840-2850.
41. Norton, J. D. 2000. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113:3897-3905.
42. Norton, J. D., and G. T. Atherton. 1998. Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol. 18:2371-2381.
43. Ohtani, N., et al. 2001. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409:1067-1070.
44. Paleari, L., et al. 2008. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif. 41:936-959.
45. Perk, J., A. Iavarone, and R. Benezra. 2005. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5:603-614.
46. Prabhu, S., A. Ignatova, S. T. Park, and X. H. Sun. 1997. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17:5888-5896.
47. Richardson, G. E., et al. 1993. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann. Intern. Med. 119:383-390.
48. Rothschild, S. I., et al. 2011. The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer 71:306-311.
49. Ruzinova, M. B., and R. Benezra. 2003. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13:410-418.
50. Schell, M., and B. Singh. 1997. The reduced monotonic regression method. J. Am. Stat. Assoc. 92:128-135.
51. Schuller, H. M. 2009. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat. Rev. Cancer 9:195-205.
52. Schuller, H. M., B. A. Jull, B. J. Sheppard, and H. K. Plummer. 2000. Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. Eur. J. Pharmacol. 393:265-277.
53. Sharma, G., and S. Vijayaraghavan. 2002. Nicotinic receptor signaling in nonexcitable cells. J. Neurobiol. 53:524-534.
54. Sharma, S. V., D. W. Bell, J. Settleman, and D. A. Haber. 2007. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7:169-181.
55. Sikder, H., et al. 2003. Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell 4:291-299.
56. Sikder, H. A., M. K. Devlin, S. Dunlap, B. Ryu, and R. M. Alani. 2003. Id proteins in cell growth and tumorigenesis. Cancer Cell 3:525-530.
57. Singh, J., K. Murata, Y. Itahana, and P. Y. Desprez. 2002. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21:1812-1822.
58. Soh, J., et al. 2008. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J. Thorac. Oncol. 3:340-347.
59. Sos, M. L., et al. 2009. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 69:3256-3261.
60. Sun, S., J. H. Schiller, and A. F. Gazdar. 2007. Lung cancer in never smokers-a different disease. Nat. Rev. Cancer 7:778-790.
61. Swarbrick, A., et al. 2005. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24:381-389.
62. Swope, S. L., and R. L. Huganir. 1994. Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases. J. Biol. Chem. 269:29817-29824.
63. Swope, S. L., Z. Qu, and R. L. Huganir. 1995. Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinases. Ann. N. Y. Acad. Sci. 757:197-214.
64. Tam, I. Y., et al. 2006. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin. Cancer Res. 12:1647-1653.
65. Villablanca, A. C. 1998. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J. Appl. Physiol. 84:2089-2098.
66. Volpert, O. V., et al. 2002. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2:473-483.
67. Wessler, I., C. J. Kirkpatrick, and K. Racke. 1998. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol. Ther. 77:59-79.
68. Wu, Y., X. Zhang, M. Salmon, and Z. E. Zehner. 2007. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. Genes Cells 12:905-918.
69. Yamamoto, H., et al. 2008. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res. 68:6913-6921.
70. Zhang, C. Z., G. G. Chen, and P. B. Lai. 2010. Transcription factor ZBP-89 in cancer growth and apoptosis. Biochim. Biophys. Acta 1806:36-41.
71. Zhang, X., I. H. Diab, and Z. E. Zehner. 2003. ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. Nucleic Acids Res. 31:2900-2914.
72. Zheng, Y., J. D. Ritzenthaler, J. Roman, and S. Han. 2007. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am. J. Respir. Cell Mol. Biol. 37:681-690.